Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin
Stock Information for Enzo Biochem Inc. ($0.01 Par Value)
Loading
Please wait while we load your information from QuoteMedia.